These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 985377)

  • 41. [Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease].
    Yang N; Han LS; Ye J; Qiu WJ; Zhang HW; Gao XL; Wang Y; Li XY; Xu H; Gu XF
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(40):2839-42. PubMed ID: 23290213
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Maple syrup urine disease metabolites studies in cerebellum cultures.
    Silberberg DH
    J Neurochem; 1969 Jul; 16(7):1141-6. PubMed ID: 5816072
    [No Abstract]   [Full Text] [Related]  

  • 43. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
    Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
    Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Classical maple syrup urine disease: cofactor resistance.
    Elsas LJ; Pask BA; Wheeler FB; Perl DP; Truster S
    Metabolism; 1972 Oct; 21(10):929-44. PubMed ID: 4342010
    [No Abstract]   [Full Text] [Related]  

  • 45. Prolongation of G1 and S phase in C-6 glioma cells treated with maple syrup urine disease metabolits. Morphologic and cell cycle studies.
    Liao CL; Herman MM; Bensch KG
    Lab Invest; 1978 Feb; 38(2):122-33. PubMed ID: 564423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease.
    Jouvet P; Rustin P; Taylor DL; Pocock JM; Felderhoff-Mueser U; Mazarakis ND; Sarraf C; Joashi U; Kozma M; Greenwood K; Edwards AD; Mehmet H
    Mol Biol Cell; 2000 May; 11(5):1919-32. PubMed ID: 10793161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease.
    Ribeiro CA; Sgaravatti AM; Rosa RB; Schuck PF; Grando V; Schmidt AL; Ferreira GC; Perry ML; Dutra-Filho CS; Wajner M
    Neurochem Res; 2008 Jan; 33(1):114-24. PubMed ID: 17680360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect.
    Mescka CP; Wayhs CA; Vanzin CS; Biancini GB; Guerreiro G; Manfredini V; Souza C; Wajner M; Dutra-Filho CS; Vargas CR
    Int J Dev Neurosci; 2013 Feb; 31(1):21-4. PubMed ID: 23137711
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y; MacDonnell RC
    Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD).
    Oglesbee D; Sanders KA; Lacey JM; Magera MJ; Casetta B; Strauss KA; Tortorelli S; Rinaldo P; Matern D
    Clin Chem; 2008 Mar; 54(3):542-9. PubMed ID: 18178665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Living related versus deceased donor liver transplantation for maple syrup urine disease.
    Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
    Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amino acids levels and lipid peroxidation in maple syrup urine disease patients.
    Barschak AG; Sitta A; Deon M; Busanello EN; Coelho DM; Cipriani F; Dutra-Filho CS; Giugliani R; Wajner M; Vargas CR
    Clin Biochem; 2009 Apr; 42(6):462-6. PubMed ID: 19121297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Branched-chain L-amino acid metabolism in classical maple syrup urine disease after orthotopic liver transplantation.
    Bodner-Leidecker A; Wendel U; Saudubray JM; Schadewaldt P
    J Inherit Metab Dis; 2000 Dec; 23(8):805-18. PubMed ID: 11196106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Branched-Chain Amino Acids and Brain Metabolism.
    Sperringer JE; Addington A; Hutson SM
    Neurochem Res; 2017 Jun; 42(6):1697-1709. PubMed ID: 28417264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A new protein substitute for adolescents and adults with maple syrup urine disease (MSUD).
    Hallam P; Lilburn M; Lee PJ
    J Inherit Metab Dis; 2005; 28(5):665-72. PubMed ID: 16151896
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transamination and oxidative decarboxylation rates of branched-chain 2-oxo acids in cultured human skin fibroblasts.
    Schadewaldt P; Radeck W; Hammen HW; Wendel U
    Pediatr Res; 1988 Jan; 23(1):40-4. PubMed ID: 3340442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. THE EXCHANGE OF 14CO2 WITH BRANCHED-CHAIN KETOACIDS BY GUINEA-PIG LIVER.
    DANCIS J; HUTZLER J; LEVITZ M
    Biochim Biophys Acta; 1963 Oct; 78():90-3. PubMed ID: 14098188
    [No Abstract]   [Full Text] [Related]  

  • 58. Hypervalinemia and hyperleucine-isoleucinemia caused by mutations in the branched-chain-amino-acid aminotransferase gene.
    Wang XL; Li CJ; Xing Y; Yang YH; Jia JP
    J Inherit Metab Dis; 2015 Sep; 38(5):855-61. PubMed ID: 25653144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Docosahexaenoic acid status in females of reproductive age with maple syrup urine disease.
    Mazer LM; Yi SH; Singh RH
    J Inherit Metab Dis; 2010 Apr; 33(2):121-7. PubMed ID: 20217236
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity.
    Korein J; Sansaricq C; Kalmijn M; Honig J; Lange B
    Int J Neurosci; 1994 Nov; 79(1-2):21-45. PubMed ID: 7744549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.